{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:18:48Z","timestamp":1787242728460,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:00:00Z","timestamp":1597968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503223"],"award-info":[{"award-number":["81503223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["17XD1403500"],"award-info":[{"award-number":["17XD1403500"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["18XD1403700"],"award-info":[{"award-number":["18XD1403700"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2019ZX09201004-002"],"award-info":[{"award-number":["2019ZX09201004-002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.biopha.2020.110683","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T12:21:48Z","timestamp":1600086108000},"page":"110683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Protective effect of picroside I against hepatic fibrosis in mice via sphingolipid metabolism, bile acid biosynthesis, and PPAR signaling pathway"],"prefix":"10.1016","volume":"131","author":[{"given":"Kai","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110683_bib0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110683_bib0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.110683_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2020.110683_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.dld.2006.11.004","article-title":"Herbal medicine in the treatment of liver diseases","volume":"39","author":"Stickel","year":"2007","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2020.110683_bib0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1478-3231.2007.01527.x","article-title":"Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation","volume":"27","author":"Luk","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2020.110683_bib0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10535-011-0024-8","article-title":"In vitro regeneration of an endangered medicinal plant Picrorhiza scrophulariiflora","volume":"55","author":"Bantawa","year":"2011","journal-title":"Biol. Plant."},{"key":"10.1016\/j.biopha.2020.110683_bib0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1049\/iet-nbt.2015.0032","article-title":"Development of nanoformulation of picroliv isolated from Picrorrhiza kurroa","volume":"10","author":"Guliani","year":"2015","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.biopha.2020.110683_bib0040","first-page":"25","article-title":"Picroliv - hepatoprotectant \u2013 immunomodulator","volume":"26","author":"Gupta","year":"2001","journal-title":"Drugs Future"},{"key":"10.1016\/j.biopha.2020.110683_bib0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0006-2952(92)90054-M","article-title":"Picroliv, picroside-I and kutkoside from Picrorhiza-kurrooa are scavengers of superoxide anions","volume":"44","author":"Chander","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110683_bib0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0773.1992.tb00566.x","article-title":"Picroliv and its components Kutkoside and Picroside I protect liver against galactosamine-induced damage in rats","volume":"71","author":"Dwivedi","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2020.110683_bib0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ptr.2650070604","article-title":"Antiinflammatory activity of the Iridoids kutkin, Picroside-1 and Kutkoside from Picrorhiza-kurrooa","volume":"7","author":"Singh","year":"1993","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2020.110683_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/751629","article-title":"A Picrorhiza kurroa derivative, Picroliv, attenuates the development of dextran-sulfate-sodium-induced colitis in mice","volume":"2012","author":"Zhang","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.biopha.2020.110683_bib0065","first-page":"149","article-title":"Hepatoprotective activities of Picroliv, curcumin, and ellagic acid compared to silymarin on carbontetrachloride-induced liver toxicity in mice","volume":"3","author":"Girish","year":"2012","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.biopha.2020.110683_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5114\/fn.2018.80867","article-title":"Protective effect of picroliv against lipopolysaccharide-induced cognitive dysfunction and neuroinflammation by attenuating TLR4\/NF-kB pathway","volume":"56","author":"Li","year":"2018","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.biopha.2020.110683_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-pharmtox-010611-134520","article-title":"Systems pharmacology: network analysis to identify multiscale mechanisms of drug action","volume":"52","author":"Zhao","year":"2012","journal-title":"Annu. Rev. Pharmacool. Toxicol."},{"key":"10.1016\/j.biopha.2020.110683_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/157016306780136763","article-title":"Proteomics approach to illustrate drug action mechanisms","volume":"3","author":"Wang","year":"2006","journal-title":"Curr. Drug Disc. Technol."},{"key":"10.1016\/j.biopha.2020.110683_bib0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2013.120","article-title":"Metabolomics in drug discovery and development","volume":"94","author":"Robertson","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2020.110683_bib0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2020.110683_bib0095","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.biopha.2020.110683_bib0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000374098","article-title":"Hepatic fibrosis: emerging therapies","volume":"33","author":"Friedman","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biopha.2020.110683_bib0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jep.2013.10.051","article-title":"Anti-fibrosis and anti-cirrhosis effects of Rhizoma paridis saponins on diethylnitrosamine induced rats","volume":"151","author":"Man","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.110683_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ajg.2014.370","article-title":"Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis","volume":"110","author":"Sands","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2020.110683_bib0115","first-page":"12","article-title":"The role of liver in determining serum colon-derived uremic solutes","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110683_bib0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11759-z","article-title":"Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach","volume":"7","author":"Chang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110683_bib0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.biopha.2020.110683_bib0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12944-016-0244-1","article-title":"Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats","volume":"15","author":"Ishikawa","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2020.110683_bib0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","article-title":"Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis","volume":"64","author":"McPhail","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110683_bib0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tips.2014.10.014","article-title":"Inhibitors of tissue transglutaminase","volume":"32","author":"Keillor","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2020.110683_bib0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0168-8278(01)00135-0","article-title":"Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis","volume":"35","author":"Grenard","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110683_bib0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jep.2016.05.040","article-title":"Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: an analysis of bile acids metabolic mechanism","volume":"189","author":"Song","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2020.110683_bib0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110683_bib0160","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","article-title":"Angiogenesis in liver disease","volume":"50","author":"Fernandez","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110683_bib0165","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.24427","article-title":"Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of Sorafenib in liver fibrosis","volume":"54","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110683_bib0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2013.02.021","article-title":"Sphingosine kinase\/sphingosine 1-phosphate (S1P)\/S1P receptor axis is involved in liver fibrosis-associated angiogenesis","volume":"59","author":"Yang","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110683_bib0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nri1650","article-title":"Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network","volume":"5","author":"Rosen","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2020.110683_bib0180","doi-asserted-by":"crossref","first-page":"37118","DOI":"10.1074\/jbc.M502207200","article-title":"SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism","volume":"280","author":"Maceyka","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.110683_bib0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2003-04-1304","article-title":"Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages","volume":"103","author":"Brownstein","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2020.110683_bib0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.dld.2017.02.013","article-title":"Annexin A2 promotes liver fibrosis by mediating von Willebrand factor secretion","volume":"49","author":"Yang","year":"2017","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2020.110683_bib0195","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110683_bib0200","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hep.21792","article-title":"Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture","volume":"46","author":"Li","year":"2007","journal-title":"Hepatology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220308763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:43:05Z","timestamp":1766083385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220308763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S0753332220308763"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110683","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of picroside I against hepatic fibrosis in mice via sphingolipid metabolism, bile acid biosynthesis, and PPAR signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110683"}}